AI
EXAS

ArchPoint Investors’s Exact Sciences EXAS Stock Holding History

ArchPoint Investors’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-8,500
Closed -$200K – 158
2017
Q1 		$200K Buy
+8,500
New +$168K 0.08% 79
2016
Q4 		– Sell
-12,000
Closed -$223K – 90
2016
Q3 		$223K Hold
12,000
– – 0.13% 80
2016
Q2 		$147K Buy
+12,000
New +$90.4K 0.08% 87

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

ArchPoint Investors's EXAS Position: Q2 2017 in Review

ArchPoint Investors sold out of Exact Sciences (EXAS) in Q2 2017, closing a stake of 8,500 shares — an estimated $200K sold.

ArchPoint Investors first reported a position in EXAS in Q2 2016 and held it in 3 quarters. The position peaked at $223K in Q3 2016. 266 funds tracked by Wall St. Rank hold EXAS as of Q2 2017.

  • ArchPoint Investors reported no remaining Exact Sciences position as of Q2 2017 after selling out during the quarter.
  • ArchPoint Investors sold 8,500 Exact Sciences shares in Q2 2017, an estimated $200K.
  • ArchPoint Investors first reported a position in Exact Sciences in Q2 2016 and held it in 3 quarters.
  • ArchPoint Investors's Exact Sciences position peaked at $223K in Q3 2016.
  • 266 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2017.

Based on ArchPoint Investors's 13F filing for Q2 2017, filed 3 Aug 2017.